Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Int J Nanomedicine ; 17: 6655-6673, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36582458

RESUMO

Purpose: Chondrosarcomas (CHSs), which represent 20% of primary bone tumors in adults, are mostly resistant to radio- and chemotherapy. It is therefore essential that new therapeutic approaches, targeted to the tumour, be developed to improve the prognosis of patients. The effectiveness, as a radiosensitizing agent, of gadolinium oxide nanoparticles (GdoNP, AGuIX®) nanoparticles in CHS was evaluated in vitro, in spheroid CHS models allowing to reproduce cell-cell extracellular matrix interactions, and, in vivo, in a nude mouse model with heterotopic tumour xenograft. Methods: Spheroids from SW1353 and HEMC-SS cells were characterized by confocal microscopy with or without GdoNP treatment. Real-time microscopy enabled quantification of cell viability, cell migration and invasion. In vivo, the efficacy of the association of GdoNP combined with a single (4Gy) or fractionated (4x1Gy) irradiation was evaluated in HEMC-SS tumor-bearing mice by monitoring tumor growth, mouse survival and gene expression profile. Results: The expression of proteoglycans in the extra-cellular matrix (ECM) of spheroids demonstrated the relevance of the 3-D model. The combination of GdoNP with single or fractionated irradiation increased the lethal effects of irradiation on 2-D- and 3-D-cultured cells. In vivo, a single or a fractionated dose of 4 Gy associated with IT or IV injection of GdoNP decreased tumor growth significantly. Only IT injection increased mice survival. Unexpectedly, the radiosensitizing effect of GdoNP was associated, in vitro, with a significant decrease in invasion-migration capacities and, in vivo, with the decreased expression of PTX3, a protein involved in the epithelial-to-mesenchymal transition process, suggesting a potential impact of GdoNP on metastasis formation. Conclusion: These results provide the first proof of concept of the radiosensitizing effect of GdoNP in CHSs and opened the way for a multicentre, randomized Phase 2 trial evaluating the association of GdoNP with radiotherapy for the therapeutic management of patients with symptomatic inoperable musculoskeletal tumor lesions.


Assuntos
Neoplasias Ósseas , Condrossarcoma , Nanopartículas , Radiossensibilizantes , Camundongos , Humanos , Animais , Radiossensibilizantes/farmacologia , Modelos Animais de Doenças , Condrossarcoma/radioterapia , Linhagem Celular Tumoral
2.
Br J Radiol ; 92(1093): 20180365, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30226413

RESUMO

AGuIX® are sub-5 nm nanoparticles made of a polysiloxane matrix and gadolinium chelates. This nanoparticle has been recently accepted in clinical trials in association with radiotherapy. This review will summarize the principal preclinical results that have led to first in man administration. No evidence of toxicity has been observed during regulatory toxicity tests on two animal species (rodents and monkeys). Biodistributions on different animal models have shown passive uptake in tumours due to enhanced permeability and retention effect combined with renal elimination of the nanoparticles after intravenous administration. High radiosensitizing effect has been observed with different types of irradiations in vitro and in vivo on a large number of cancer types (brain, lung, melanoma, head and neck…). The review concludes with the second generation of AGuIX nanoparticles and the first preliminary results on human.


Assuntos
Gadolínio/administração & dosagem , Nanopartículas/administração & dosagem , Radiossensibilizantes/administração & dosagem , Nanomedicina Teranóstica/métodos , Animais , Neoplasias Encefálicas/patologia , Neoplasias Encefálicas/terapia , Previsões , Neoplasias de Cabeça e Pescoço/diagnóstico , Neoplasias de Cabeça e Pescoço/terapia , Humanos , Melanoma/patologia , Melanoma/terapia , Camundongos , Nanomedicina Teranóstica/tendências
3.
Crit Rev Oncol Hematol ; 126: 32-36, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29759564

RESUMO

Chondrosarcomas are characterized by their chemo- and radioresistance leading to a therapeutic surgical approach which remains the only available treatment with a 10-year survival between 30% and 80% depending on the grade. Non-surgical treatments are under investigation and rely on an accurate biological understanding of drug resistance mechanisms. Novel targeted therapy which represents a new relevant therapeutic approach will open new treatment options by targeting several pathways responsible for processes of proliferation and invasion. Survival pathways such as PI3K, AKT, mTOR and VEGF have been shown to be involved in proliferation of chondrosarcoma cells and antiapoptotic proteins may also play a relevant role. Other proteins such as p53 or COX2 have been identified as potential new targets. This review provides an insight into the biological substantial treatment challenges of CHS and focuses on improving our understanding of CH biology through an overview of major signaling pathways that could represent targets for new therapeutic approaches.


Assuntos
Neoplasias Ósseas/metabolismo , Neoplasias Ósseas/patologia , Neoplasias Ósseas/terapia , Condrossarcoma/metabolismo , Condrossarcoma/patologia , Condrossarcoma/terapia , Resistencia a Medicamentos Antineoplásicos/fisiologia , Drogas em Investigação/uso terapêutico , Humanos , Terapia de Alvo Molecular/métodos , Terapia de Alvo Molecular/tendências , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Transdução de Sinais/fisiologia , Serina-Treonina Quinases TOR/metabolismo , Terapias em Estudo/métodos , Terapias em Estudo/tendências
4.
Nanomedicine ; 13(8): 2655-2660, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28779947

RESUMO

Hadrontherapy presents the major advantage of improving tumor sterilization while sparing surrounding healthy tissues because of the particular ballistic (Bragg peak) of carbon ions. However, its efficacy is still limited in the most resistant cancers, such as grade III-IV head and neck squamous cell carcinoma (HNSCC), in which the association of carbon ions with gadolinium-based nanoparticles (AGuIX®) could be used as a Trojan horse. We report for the first time the radioenhancing effect of AGuIX® when combined with carbon ion irradiation in human tumor cells. An increase in relative biological effectiveness (1.7) in three HNSCC cell lines (SQ20B, FaDu, and Cal33) was associated with a significant reduction in the radiation dose needed for killing cells. Radiosensitization goes through a higher number of unrepaired DNA double-strand breaks. These results underline the strong potential of AGuIX® in sensitizing aggressive tumors to hadrontherapy and, therefore, improving local control while lowering acute/late toxicity.


Assuntos
Carbono/uso terapêutico , Carcinoma de Células Escamosas/radioterapia , Gadolínio/uso terapêutico , Neoplasias de Cabeça e Pescoço/radioterapia , Nanopartículas/uso terapêutico , Radiossensibilizantes/uso terapêutico , Carcinoma de Células Escamosas/patologia , Linhagem Celular Tumoral , Neoplasias de Cabeça e Pescoço/patologia , Humanos , Modelos Moleculares
5.
Nanomedicine ; 11(1): 247-57, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24983891

RESUMO

Gadolinium based nanoparticles (GBNs, diameter 2.9±0.2nm), have promising biodistribution properties for theranostic use in-vivo. We aimed at demonstrating the radiosensitizing effect of these GBNs in experimental radioresistant human head and neck squamous cell carcinoma (SQ20B, FaDu and Cal33 cell lines). Combining 0.6mM GBNs with 250kV photon irradiation significantly decreased SQ20B cell survival, associated with an increase in non-reparable DNA double-strand breaks, the shortening of G2/M phase blockage, and the inhibition of cell proliferation, each contributing to the commitment of late apoptosis. Similarly, radiation resistance was overcome for SQ20B stem-like cells, as well as for FaDu and Cal33 cell lines. Using a SQ20B tumor-bearing mouse model, combination of GBNs with 10Gy irradiation significantly delayed tumor growth with an increase in late apoptosis and a decrease in cell proliferation. These results suggest that GBNs could be envisioned as adjuvant to radiotherapy for HNSCC tumors.


Assuntos
Carcinoma de Células Escamosas/tratamento farmacológico , Gadolínio/química , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Nanopartículas/química , Radiossensibilizantes/química , Animais , Apoptose , Carcinoma de Células Escamosas/patologia , Caspase 2/metabolismo , Linhagem Celular Tumoral , Proliferação de Células , Sobrevivência Celular , Dano ao DNA , Feminino , Citometria de Fluxo , Neoplasias de Cabeça e Pescoço/patologia , Histonas/química , Humanos , Camundongos , Camundongos Nus , Microscopia Confocal , Microscopia de Fluorescência , Nanomedicina , Radioterapia
6.
Cell Stress Chaperones ; 18(5): 623-30, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23508575

RESUMO

Despite the strong rationale for combining cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal carcinomatosis, thermotolerance and chemoresistance might result from heat shock protein overexpression. The aim of the present study was thus to determine whether the heat shock protein 27 (Hsp27), a potential factor in resistance to treatment, could have a higher level in serum from patients under this combined therapy. Patients receiving CRS plus HIPEC for peritoneal carcinomatosis (group 1), patients with cancer or a history of cancer undergoing abdominal surgery (group 2), and patients without malignancies undergoing abdominal surgery (group 3) were included. Hsp27 serum levels were determined before and at different times following CRS and HIPEC using enzyme-linked immunosorbent assay. In group 1 (n = 25), the high Hsp27 levels, observed at the end of surgery compared with before (p < 0.0001), decreased during HIPEC, but remained significantly higher than before surgery (p < 0.0005). In groups 2 (n = 11) and 3 (n = 15), surgery did not significantly increase Hsp27 levels. A targeted molecular strategy, inhibiting Hsp27 expression in tumor tissue, could significantly reduce resistance to the combined CRS plus HIPEC treatment. This approach should be further assessed in a clinical phase I trial.


Assuntos
Antineoplásicos/uso terapêutico , Carcinoma/tratamento farmacológico , Ensaio de Imunoadsorção Enzimática , Proteínas de Choque Térmico HSP27/sangue , Neoplasias Peritoneais/tratamento farmacológico , Adulto , Idoso , Proteína C-Reativa/análise , Carcinoma/patologia , Carcinoma/cirurgia , Cisplatino/uso terapêutico , Terapia Combinada , Resistencia a Medicamentos Antineoplásicos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mitomicina/uso terapêutico , Neoplasias Peritoneais/patologia , Neoplasias Peritoneais/cirurgia
7.
Biomaterials ; 34(1): 181-95, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23046756

RESUMO

Over the last few decades, nanoparticles have been studied in theranostic field with the objective of exhibiting a long circulation time through the body coupled to major accumulation in tumor tissues, rapid elimination, therapeutic potential and contrast properties. In this context, we developed sub-5 nm gadolinium-based nanoparticles that possess in vitro efficient radiosensitizing effects at moderate concentration when incubated with head and neck squamous cell carcinoma cells (SQ20B). Two main cellular internalization mechanisms were evidenced and quantified: passive diffusion and macropinocytosis. Whereas the amount of particles internalized by passive diffusion is not sufficient to induce in vitro a significant radiosensitizing effect, the cellular uptake by macropinocytosis leads to a successful radiotherapy in a limited range of particles incubation concentration. Macropinocytosis processes in two steps: formation of agglomerates at vicinity of the cell followed by their collect via the lamellipodia (i.e. the "arms") of the cell. The first step is strongly dependent on the physicochemical characteristics of the particles, especially their zeta potential that determines the size of the agglomerates and their distance from the cell. These results should permit to control the quantity of particles internalized in the cell cytoplasm, promising ambitious opportunities towards a particle-assisted radiotherapy using lower radiation doses.


Assuntos
Gadolínio/metabolismo , Nanopartículas/química , Neoplasias/metabolismo , Neoplasias/patologia , Pinocitose , Radiossensibilizantes/metabolismo , Linhagem Celular Tumoral , Membrana Celular/metabolismo , Membrana Celular/ultraestrutura , Sobrevivência Celular/efeitos dos fármacos , Difusão , Humanos , Cinética , Nanopartículas/ultraestrutura , Tamanho da Partícula , Pseudópodes/metabolismo , Fatores de Tempo , Vacúolos/metabolismo , Vacúolos/ultraestrutura
8.
Mol Ther ; 17(8): 1387-94, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19436268

RESUMO

In a wide range of human cancers, increased levels of heat shock protein 27 (Hsp27) are closely associated with tumorigenesis, metastasis, resistance to anticancer therapeutics, and thus poor prognosis. In this study, we evaluate the radiosensitizing effects of Hsp27 gene silencing using OGX-427, a second-generation antisense oligonucleotide (ASO), on the radioresistant head and neck squamous cell carcinoma (HNSCC) SQ20B cells. In vitro, the downregulation of Hsp27 significantly enhanced radiation-induced apoptotic and clonogenic death, and promoted Akt inactivation. In vivo, combining OGX-427 with local tumor irradiation (5 x 2 Gy) led to a significant regression of SQ20B tumors related to a high rate of apoptosis and decreased levels of glutathione antioxidant defenses. Increasing the total radiation dose (15 x 2 Gy) significantly amplified the radiosensitizing effect of OGX-427. Treatment of tumors with OGX-427 plus radiation resulted in a decrease in angiogenesis associated with a reduced activation of the Akt pathway. Furthermore, the combined treatment enhanced the survival of SQ20B-bearing mice and showed no signs of acute and delayed toxicity. Our findings demonstrate for the first time that Hsp27 knockdown enhances the cytotoxic effects of radiotherapy in vivo and provide preclinical proof of principle for clinical trials using Hsp27 antisense technology in the treatment of patients with HNSCC radioresistant cancers.


Assuntos
Proteínas de Choque Térmico HSP27/genética , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Oligonucleotídeos Antissenso/uso terapêutico , Radiossensibilizantes/uso terapêutico , Animais , Apoptose/efeitos dos fármacos , Carcinoma de Células Escamosas/tratamento farmacológico , Carcinoma de Células Escamosas/radioterapia , Linhagem Celular Tumoral , Feminino , Proteínas de Choque Térmico HSP27/farmacologia , Neoplasias de Cabeça e Pescoço/radioterapia , Humanos , Imuno-Histoquímica , Camundongos , Camundongos Nus , Oligonucleotídeos Antissenso/genética , Oligonucleotídeos Antissenso/farmacologia , Radiossensibilizantes/farmacologia , Ensaios Antitumorais Modelo de Xenoenxerto
9.
Int J Radiat Oncol Biol Phys ; 70(2): 543-53, 2008 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-17980509

RESUMO

PURPOSE: The ability of heat shock protein 27 (Hsp27) to protect cells from stressful stimuli and its increased levels in tumors resistant to anticancer therapeutics suggest that it may represent a target for sensitization to radiotherapy. In this study, we investigate the protective role of Hsp27 against radiation-induced apoptosis and the effect of its attenuation in highly expressing radioresistant cancer cell lines. METHODS AND MATERIALS: We examined clonogenic death and the kinetics of apoptotic events in different tumor cell lines overexpressing or underexpressing Hsp27 protein irradiated with photons. The radiosensitive Jurkat cell line, which does not express Hsp27 constitutively or in response to gamma-rays, was stably transfected with Hsp27 complementary DNA. Attenuation of Hsp27 expression was accomplished by antisense or RNAi (interfering RNA) strategies in SQ20B head-and-neck squamous carcinoma, PC3 prostate cancer, and U87 glioblastoma radioresistant cells. RESULTS: We measured concentration-dependent protection against the cytotoxic effects of radiation in Jurkat-Hsp27 cells, which led to a 50% decrease in apoptotic cells at 48 hours in the highest expressing cells. Underlying mechanisms leading to radiation resistance involved a significant increase in glutathione levels associated with detoxification of reactive oxygen species, a delay in mitochondrial collapse, and caspase activation. Conversely, attenuation of Hsp27 in SQ20B cells, characterized by their resistance to apoptosis, sensitizes cells to irradiation. This was emphasized by increased apoptosis, decreased glutathione basal level, and clonogenic cell death. Sensitization to irradiation was confirmed in PC3 and U87 radioresistant cells. CONCLUSION: Hsp27 gene therapy offers a potential adjuvant to radiation-based therapy of resistant tumors.


Assuntos
Apoptose/efeitos da radiação , Inativação Gênica/fisiologia , Proteínas de Choque Térmico/fisiologia , Proteínas de Neoplasias/fisiologia , Tolerância a Radiação/fisiologia , Apoptose/fisiologia , Caspases/metabolismo , Linhagem Celular Tumoral/efeitos da radiação , Regulação para Baixo , Ativação Enzimática/efeitos da radiação , Raios gama , Glioblastoma/metabolismo , Glioblastoma/radioterapia , Glutationa/metabolismo , Neoplasias de Cabeça e Pescoço/metabolismo , Neoplasias de Cabeça e Pescoço/radioterapia , Proteínas de Choque Térmico/genética , Proteínas de Choque Térmico/metabolismo , Humanos , Células Jurkat/efeitos da radiação , Masculino , Mitocôndrias/fisiologia , Mitocôndrias/efeitos da radiação , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Estresse Oxidativo/fisiologia , Estresse Oxidativo/efeitos da radiação , Fótons , Neoplasias da Próstata/metabolismo , Neoplasias da Próstata/radioterapia , RNA Antissenso/uso terapêutico , RNA Interferente Pequeno/uso terapêutico , Tolerância a Radiação/genética , Espécies Reativas de Oxigênio/metabolismo , Fatores de Tempo , Transfecção/métodos , Ensaio Tumoral de Célula-Tronco
10.
Oncogene ; 23(15): 2703-15, 2004 Apr 08.
Artigo em Inglês | MEDLINE | ID: mdl-15048093

RESUMO

Recent strategies to sensitize radioresistant tumours are based on combining gamma-irradiation with inducers of apoptosis. We report that the combination of three inhibitors of sphingolipid metabolism, DL-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol.HCl(DL-PDMP)+imipramine +/- D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol (D-MAPP), with 10-Gy irradiation triggers both mitotic and apoptotic killing in radioresistant SQ20B squamous carcinoma cells. In these cells, apoptosis is defective due to a lack of ceramide generation upstream, which cannot be explained by sphingomyelinase (neutral and acidic) deficiency or rapid derivation to the sphingolipid pathway. We present evidence of a functional transduction death pathway when ceramide generation is restored, which involves the mitochondrial-mediated pathway coupled to alterations in redox status and to executive caspases activation. The poly-drug treatment restored apoptosis to levels similar to those observed in radiosensitive SCC61 squamous carcinoma cells. Simultaneous exposure to gamma-irradiation and poly-drug treatment acted synergistically in SQ20B cells to produce a marked increase in both mitochondrial dysfunction and caspase cleavage, which led to a 7.8-fold increase in apoptosis within 48 h, relative to irradiated cells. Moreover, the results suggest that the ceramide released by irradiation or poly-drug treatment converges upon common cellular targets. Modulation of endogenous ceramide levels by inhibitors of sphingolipid metabolism may represent a new cellular target for the sensitization of radioresistant tumours to gamma-ray therapy.


Assuntos
Carcinoma de Células Escamosas/radioterapia , Ceramidas/farmacologia , Apoptose , Western Blotting , Carcinoma de Células Escamosas/metabolismo , Caspase 3 , Caspase 8 , Inibidores de Caspase , Caspases/biossíntese , Caspases/metabolismo , Linhagem Celular Tumoral , Ceramidas/metabolismo , Cromatografia Líquida de Alta Pressão , Relação Dose-Resposta à Radiação , Ativação Enzimática , Citometria de Fluxo , Raios gama , Glucosiltransferases/metabolismo , Glutationa/metabolismo , Neoplasias de Cabeça e Pescoço/metabolismo , Neoplasias de Cabeça e Pescoço/radioterapia , Humanos , Cinética , Mitocôndrias/metabolismo , Mitose , Miristatos/farmacologia , Ácido N-Acetilneuramínico/metabolismo , Oxirredução , Propanolaminas/farmacologia , Espécies Reativas de Oxigênio , Esfingolipídeos/antagonistas & inibidores , Fatores de Tempo
11.
Int J Cancer ; 101(6): 589-98, 2002 Oct 20.
Artigo em Inglês | MEDLINE | ID: mdl-12237902

RESUMO

To enhance the killing effects of ionizing radiation, we amplified the endogenous ceramide signal in Jurkat cell cultures using 3 different inhibitors of sphingolipid metabolism: DL-PDMP, D-MAPP and imipramine. Of the various possible drug combinations, only DL-PDMP (20 microM) + imipramine (20 microM) and DL-PDMP (20 microM) + imipramine (20 microM) + D-MAPP (5 microM) induced a major increase in ceramide levels, reaching 240% and 340% of control values, respectively, after incubation for 48 hr. With these models, we demonstrate that endogenously formed ceramide triggers time- and concentration-dependent apoptosis through induction of mitochondrial injury and activation of the caspase pathway. Cellular dysfunction includes alterations to the cellular redox potential, as assessed by the generation of ROS and total glutathione depletion, and a drop in Delta Psi(m). A parallel elevation of mitochondrial ceramide levels was also observed. The combination of DL-PDMP + imipramine +/- D-MAPP with 10 Gy irradiation produced cumulative effects leading to apoptosis via mitochondrial collapse and activation of the caspase cascade. The association efficiency was confirmed in normal and acid sphingomyelinase-deficient lymphoid cell lines. Taken together, these results suggest that increasing endogenous ceramide levels may potentially be very valuable when combined with ionizing radiation in tumor therapy.


Assuntos
Apoptose/efeitos dos fármacos , Apoptose/efeitos da radiação , Ceramidas/metabolismo , Imipramina/farmacologia , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/efeitos da radiação , Morfolinas/farmacologia , Miristatos/farmacologia , Propanolaminas/farmacologia , Caspases/metabolismo , Ciclo Celular/efeitos dos fármacos , Ciclo Celular/efeitos da radiação , Relação Dose-Resposta a Droga , Relação Dose-Resposta à Radiação , Citometria de Fluxo , Glutationa/metabolismo , Humanos , Células Jurkat , Mitocôndrias/patologia , Radiação Ionizante , Espécies Reativas de Oxigênio/metabolismo , Esfingolipídeos/biossíntese , Esfingolipídeos/metabolismo , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA